Snl Pharma Llp - Company Profile

It is a paper limited liability partnership based in Rajkot, Gujarat, India, established in 2023.
2023 Rajkot, Gujarat, India Active
Last Updated:
Access Report
About Snl Pharma Llp

Snl Pharma Llp, a active limited liability partnership, was established on 09 November 2023 in Rajkot, Gujarat, India. Engaging in manufacturing within the paper sector, it holds LLPIN: ACD-8573. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹2.10 Cr.

Its leadership includes Shilpa Devendrabhai Sheth (Designated Partner), Jenil Devendrabhai Sheth (Designated Partner). Past directors included Lalitkumar Bachubhai Kapadia. It holds ₹9.90 Cr open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at Yamuna Metachem, Office No. 01, Bh. Shel Petrolpump, Makkam Chowk, Gondal Road,, Rajkot, Gujarat, 360002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACD-8573

  • Incorporation Date

    09 November 2023

  • Total Obligation of Contribution

    ₹2.10 Cr

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 2.10 Cr
  • Company Age 2 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 9.90 Cr
Company report

Snl Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Snl Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Snl Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Shilpa Devendrabhai Sheth Designated Partner 09 Nov 2023 Current
Jenil Devendrabhai Sheth Designated Partner 09 Nov 2023 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 02 Dec 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Snl Pharma Llp.

Enhance accessibility to Snl Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Snl Pharma Llp revenue growth over time
Snl Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Snl Pharma Llp?

Unlock access to Snl Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹99,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sidbi : 9.90 Cr
Latest Charge Details
Date Lender Amount Status
13 Aug 2024 Sidbi ₹9.90 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Snl Pharma Llp?

Unlock and access historical data on people associated with Snl Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Snl Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snl Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Snl Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Snl Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Snl Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Charges

    The activity A charge with Sidbi of Rs. 9.90 Cr registered on 13 Aug 2024 with Charge ID 100980068 was modified on 25 Sep 2024. was completed.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 9.90 Cr with Charge ID 100980068 was registered on 13 Aug 2024. was documented.

  • Director Appointment

    The activity Shilpa Devendrabhai Sheth was appointed as a Designated Partner was appointed as a Designated Partner on 09 Nov 2023 & has been associated with this company since 2 years 3 months . was completed.

  • Director Appointment

    The activity Jenil Devendrabhai Sheth was appointed as a Designated Partner was appointed as a Designated Partner on 09 Nov 2023 & has been associated with this company since 2 years 3 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Snl Pharma Llp?

The LLPIN of Snl Pharma Llp is ACD-8573.

Where is Snl Pharma Llp headquartered?

Snl Pharma Llp is headquartered at Yamuna Metachem, Office No. 01, Bh. Shel Petrolpump, Makkam Chowk, Gondal Road,, Rajkot, Gujarat, 360002.

When was Snl Pharma Llp incorporated?

Snl Pharma Llp was incorporated on 09 November 2023.

Who are the current directors of Snl Pharma Llp?

The current directors of Snl Pharma Llp are

What is the primary industry of Snl Pharma Llp?

The primary industry of Snl Pharma Llp is Paper.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available